Domača stranGEHC • NASDAQ
add
GE HealthCare Technologies Inc
75,61 $
Po zaprtju:(0,066 %)+0,050
75,66 $
Konec trgovanja: 5. nov., 16:31:32 GMT -5 · USD · NASDAQ · Izjava
Prejšnji trg. dan.
74,30 $
Dnevni razpon
73,31 $ - 76,81 $
Letni razpon
57,65 $ - 94,80 $
Tržna kapitalizacija
34,44 mrd. USD
Povprečni obseg
3,26 mio.
Razm. P/E
15,63
Dividendna donosnost
0,19 %
Primarna borza
NASDAQ
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | sep. 2025info | Sprememba L/L |
|---|---|---|
Prihodek | 5,14 mrd. | 5,76 % |
Stroški poslovanja | 1,26 mrd. | 1,13 % |
Čisti dohodek | 446,00 mio. | −5,11 % |
Čista dobičkovnost prihodkov | 8,67 | −10,25 % |
Earnings per share | 1,07 | −6,14 % |
EBITDA | 879,00 mio. | −4,87 % |
Efektivna davčna stopnja | 27,84 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | sep. 2025info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 4,00 mrd. | 12,82 % |
Skupna sredstva | 36,13 mrd. | 6,71 % |
Skupne obveznosti | 25,91 mrd. | 2,23 % |
Celoten lastniški kapital | 10,22 mrd. | — |
Shares outstanding | 455,52 mio. | — |
Razmerje P/B | 3,39 | — |
Donosnost sredstev | 5,10 % | — |
Donosnost kapitala | 8,78 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | sep. 2025info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 446,00 mio. | −5,11 % |
Denar iz dejavnosti | 593,00 mio. | — |
Denar iz naložb | −148,00 mio. | — |
Denar iz financiranja | −165,00 mio. | — |
Neto sprememba denarnih sredstev | 264,00 mio. | — |
Prost denarni tok | 415,88 mio. | — |
Vizitka
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals.
The company's primary customers are hospitals and health networks. In 2023, the company received 42% of its revenue in the United States and 13% of its revenue from China, where the company faces increasing competition.
The company operates in more than 100 countries. GE HealthCare has major regional operations in Buc, France; Helsinki, Finland; Kraków, Poland; Budapest, Hungary; Yizhuang, China; Hino & Tokyo, Japan, and Bangalore, India. Its biggest R&D center is in Bangalore, India, built at a cost of $50 million. Wikipedia
Generalni direktor
Datum ustanovitve
1994
Sedež organizacije
Spletno mesto
Zaposleni
53.000
